Share price will continue to be under pressureUnfortunately today's reported results and feedback from King Paul don't leave a very inspiring outlook for company shares in the near to mid term. Could be a few quarters away yet from any meaningful share price appreciation. Paul lost his credibility pumping not only biocloud but other aspects of the business over the past couple of years and should take full credit for why the share price langers where it is. No need to get excited here. ne cannot trust the message that management spits out.